 |
 Video: What is a Stock Split?
|
|
|
| Nightstar Therapeutics is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. Co. is developing a pipeline of proprietary product candidates that are designed to substantially modify or halt the progression of inherited retinal diseases for which there are no approved treatments. Co.'s lead product candidate, NSR-REP1, for the treatment of choroideremia, or CHM. Co. is also conducting a Phase 1/2 clinical trial with Co.'s second product candidate, NSR-RPGR. Co.'s third product candidate, NSR-BEST1. According to our NITE split history records, NITE has had 1 split. | |
|
NITE (NITE) has 1 split in our NITE split history database. The split for NITE took place on May 17, 1999. This was a 2 for 1
split, meaning for each share of NITE owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as NITE splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the NITE split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NITE shares, starting with a $10,000 purchase of NITE, presented on a split-history-adjusted basis factoring in the complete NITE split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/29/2017 |
|
| End date: |
06/07/2019 |
|
| Start price/share: |
$19.20 |
|
| End price/share: |
$25.41 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
32.34% |
|
| Average Annual Total Return: |
18.06% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,233.84 |
|
| Years: |
1.69 |
|
|
|
| Date |
Ratio |
| 05/17/1999 | 2 for 1
|
|
|
